Viewing Study NCT07013760


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-27 @ 11:32 PM
Study NCT ID: NCT07013760
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module